Shandong Weigao Blood Purification Products Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Employees
  • 3,734

Employees

  • Stock Symbol
  • 603014

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $5.25
  • (As of Friday Closing)

Shandong Weigao Blood Purification Products General Information

Description

Shandong Weigao Blood Purification Products Co Ltd engaged in research and development, production and sales of blood purification medical products.

Contact Information

Formerly Known As
Weihai Weigao Blood Purification Products Co., Ltd.
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • No. 7, Weigao West Road
  • Weihai Torch High-tech Industrial Development Zone
  • Weihai, Shandong
  • China
+86 400
Primary Industry
Diagnostic Equipment
Other Industries
Medical Supplies
Therapeutic Devices
Pharmaceuticals
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • No. 7, Weigao West Road
  • Weihai Torch High-tech Industrial Development Zone
  • Weihai, Shandong
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shandong Weigao Blood Purification Products Stock Performance

As of 13-Nov-2026, Shandong Weigao Blood Purification Products’s stock price is $5.25. Its current market cap is $3.65B with 695M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.25 $5.16 $4.28 - $6.24 $3.65B 695M 1.51M $0.18

Shandong Weigao Blood Purification Products Financials Summary

As of 30-Sep-2026, Shandong Weigao Blood Purification Products has a trailing 12-month revenue of $634M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 2,795,760 1,993,043
Revenue 633,694 524,065 502,270 499,251
EBITDA 88,114 114,410 109,148 96,591
Net Income 75,366 67,067 62,626 62,484
Total Assets 1,910,583 1,230,365 957,541 942,611
Total Debt 27,036 418 1,548 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Shandong Weigao Blood Purification Products Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Shandong Weigao Blood Purification Products‘s full profile, request access.

Request a free trial

Shandong Weigao Blood Purification Products Patents

Shandong Weigao Blood Purification Products Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-202024104193-U1 An internal filtration-enhanced dialyzer Active 28-Apr-2024
DE-202024102977-U1 Dialyzer and potting cap Active 20-Jul-2023
WO-2024255585-A1 Microfiltration membrane and preparation method therefor Inactive 12-Jun-2023 B01D69/10

Shandong Weigao Blood Purification Products Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shandong Weigao Blood Purification Products Investments & Acquisitions (3)

Shandong Weigao Blood Purification Products’s most recent deal was a Merger/Acquisition with Weigao Pury for . The deal was made on 11-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Weigao Pury 11-Sep-2026 Merger/Acquisition Medical Supplies
ClonOrgan 07-Aug-2026 Later Stage VC Biotechnology
Weigao Nikkiso (Weihai) Dialysis Machine 21-May-2010 Joint Venture Therapeutic Devices
To view Shandong Weigao Blood Purification Products’s complete investments and acquisitions history, request access »

Shandong Weigao Blood Purification Products ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Shandong Weigao Blood Purification Products’s complete esg history, request access »

Shandong Weigao Blood Purification Products Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Weigao Pury Weihai, China 2005

Shandong Weigao Blood Purification Products FAQs

  • When was Shandong Weigao Blood Purification Products founded?

    Shandong Weigao Blood Purification Products was founded in 2004.

  • Where is Shandong Weigao Blood Purification Products headquartered?

    Shandong Weigao Blood Purification Products is headquartered in Weihai, China.

  • What is the size of Shandong Weigao Blood Purification Products?

    Shandong Weigao Blood Purification Products has 3,734 total employees.

  • What industry is Shandong Weigao Blood Purification Products in?

    Shandong Weigao Blood Purification Products’s primary industry is Diagnostic Equipment.

  • Is Shandong Weigao Blood Purification Products a private or public company?

    Shandong Weigao Blood Purification Products is a Public company.

  • What is Shandong Weigao Blood Purification Products’s stock symbol?

    The ticker symbol for Shandong Weigao Blood Purification Products is 603014.

  • What is the current stock price of Shandong Weigao Blood Purification Products?

    As of 13-Nov-2026 the stock price of Shandong Weigao Blood Purification Products is $5.25.

  • What is the current market cap of Shandong Weigao Blood Purification Products?

    The current market capitalization of Shandong Weigao Blood Purification Products is $3.65B.

  • What is Shandong Weigao Blood Purification Products’s current revenue?

    The trailing twelve month revenue for Shandong Weigao Blood Purification Products is $634M.

  • What is Shandong Weigao Blood Purification Products’s annual earnings per share (EPS)?

    Shandong Weigao Blood Purification Products’s EPS for 12 months was $0.18.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process